Clinical Trials Browser

Congenital Abnormalities, Abortion, Spontaneous, Birth Weight, Eclampsia, Fetal Death, Hydatidiform Mole, Obstetric Labor, Premature, Pre-Eclampsia, Pregnancy Complications, Pregnancy, Ectopic, Diabetes, Gestational, Premature Birth, Stillbirth, Maternal Death

NCT05637892 2022-12-08

A Cohort Study of Hydatidiform Mole

Not yet recruiting

800 enrolled

Hydatidiform Mole

NCT01535053 2022-08-12

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

Phase 3 Completed

57 enrolled 12 charts

Choriocarcinoma, Hydatidiform Mole

NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Phase 2/3 Unknown

200 enrolled

Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT04756713 2022-05-27

ReCure

Phase 3 Unknown

150 enrolled

Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT01984099 2020-04-17

RCT on the Efficacy of Methotrexate for the Prevention of GTD

Phase 3 Completed

99 enrolled

Hydatidiform Mole

NCT00003702 2018-05-15

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

Phase 3 Completed

240 enrolled 9 charts

Hydatidiform Mole

NCT00521118 2017-08-24

Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors

Phase 2 Completed

64 enrolled

Hydatidiform Mole

NCT02892877 2016-09-08

French GTDC

Recruiting

25,500 enrolled

Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Hydatidiform Mole, Trophoblastic Neoplasms, Trophoblastic Tumor, Placental Site, Gestational Trophoblastic Disease

NCT01630954 2016-03-23

A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole

Phase 4 Unknown

120 enrolled

Hydatidiform Mole

NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

Phase 3 Completed

100 enrolled

Gynecologic

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease

NCT00190918 2007-08-09

A Trial for Patients With Gestational Trophoblastic Disease

Phase 2 Completed

50 enrolled

Gynecologic

Choriocarcinoma, Hydatidiform Mole, Trophoblastic Neoplasms, Uterine Neoplasms

Clinical Trials

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

CN-HM-01

The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

A Cohort Study of Hydatidiform Mole

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

ReCure

RCT on the Efficacy of Methotrexate for the Prevention of GTD

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors

French GTDC

A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

A Trial for Patients With Gestational Trophoblastic Disease